Literature DB >> 7925211

Pharmacodynamics and pharmacokinetics of rocuronium following continuous infusion in patients during intravenous anaesthesia.

H J Sparr1, K S Khuenl-Brady, L I Eriksson.   

Abstract

After an initial bolus dose (0.6 mg kg-1), 10 patients received a continuous infusion of rocuronium, initially at 0.5 mg kg-1h-1, and then adjusted to maintain 90% twitch depression. Blood samples were analysed for 420 min after switching off the infusion. The dose required to maintain the block was 595 +/- 146 micrograms kg-1h-1, 7-9 times that reported for vecuronium under similar conditions. The pharmacokinetic parameters (volume of distribution at steady state, 309 +/- 80 ml kg-1, plasma clearance 4.5 +/- 1.96 ml kg-1 min-1, and elimination half-life 107 +/- 37 min) were similar to those previously reported after a large single bolus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7925211

Source DB:  PubMed          Journal:  Eur J Anaesthesiol Suppl        ISSN: 0952-1941


  7 in total

Review 1.  Clinical pharmacokinetics of the newer neuromuscular blocking drugs.

Authors:  D P Atherton; J M Hunter
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

2.  Continuous infusion of rocuronium in a paediatric intensive care unit.

Authors:  J D Tobias
Journal:  Can J Anaesth       Date:  1996-04       Impact factor: 5.063

Review 3.  Newer neuromuscular blocking agents: how do they compare with established agents?

Authors:  H J Sparr; T M Beaufort; T Fuchs-Buder
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 4.  Clinical pharmacokinetics of rocuronium bromide.

Authors:  K S Khuenl-Brady; H Sparr
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

5.  NEUROMUSCULAR BLOCKADE AND INTUBATION CONDITIONS OF THE SINGLE BOLUS DOSE (2xED90) OF ROCURONIUM BROMIDE.

Authors:  Yudhvir Suri; N S Lamba; Rbm Krishna
Journal:  Med J Armed Forces India       Date:  2017-06-08

6.  The relationship of the anthropometric variables to the infusion rate of rocuronium in the elderly.

Authors:  Bon Nyeo Koo; Sun Jun Bai; Yang-Sik Shin; Woo Chang Lee
Journal:  Yonsei Med J       Date:  2005-10-31       Impact factor: 2.759

7.  Infusion dose requirement of rocuronium in patients on phenytoin therapy - A prospective comparative study.

Authors:  Veena Sheshadri; Arathi Radhakrishnan; Kusuma Halemani; Venkatesh H Keshavan
Journal:  Indian J Anaesth       Date:  2017-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.